# Crinetics Pharmaceuticals, Inc. (CRNX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CRNX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 35.85M | $ -248.70M | $ -220.24M | $ 47.19M | $ 1.19B |
| 2025 | $ 7.88M | $ -476.44M | $ -392.86M | $ 48.54M | $ 992.08M |
| 2024 | $ 1.09M | $ -313.65M | $ -241.55M | $ 51.72M | $ 1.32B |
| 2023 | $ 4.34M | $ -231.96M | $ -184.89M | $ 51.73M | $ 539.11M |
| 2022 | $ 5.29M | $ -183.11M | $ -130.55M | $ 3.08M | $ 316.33M |
| 2021 | $ 1.28M | $ -127.95M | $ -105.82M | $ 4.01M | $ 331.94M |
| 2020 | $ 0 | $ -94.03M | $ -79.25M | $ 4.01M | $ 168.92M |
| 2019 | $ 0 | $ -65.08M | $ -60.50M | $ 5.57M | $ 117.14M |
| 2018 | $ 0 | $ -35.81M | $ -27.10M | $ 0 | $ 160.23M |
| 2017 | $ 0 | $ -12.34M | $ -13.18M | $ 0 | $ -15.02M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.04 |
| Liabilities / Eq | 0.11 |
| Current Ratio | 15.57 |

## Other views

- [Metrics](https://sponda.capital/en/CRNX.md)
- [Charts](https://sponda.capital/en/CRNX/charts.md)
- [Compare](https://sponda.capital/en/CRNX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.